Eurobio Scientific Société anonyme (ALERS.PA)
EUR 23.8
(-5.93%)
EUR 23.8
(-5.93%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 53.96 Million EUR | -18.02% |
| 2022 | 65.04 Million EUR | -33.25% |
| 2021 | 97.44 Million EUR | -7.73% |
| 2020 | 105.61 Million EUR | 475.66% |
| 2019 | 18.34 Million EUR | 4.3% |
| 2018 | 17.58 Million EUR | 35.74% |
| 2017 | 12.95 Million EUR | 169.34% |
| 2016 | 4.81 Million EUR | 2.56% |
| 2015 | 4.69 Million EUR | -41.24% |
| 2014 | 7.98 Million EUR | 4.31% |
| 2013 | 7.65 Million EUR | 54.98% |
| 2012 | 4.93 Million EUR | -1.1% |
| 2011 | 4.99 Million EUR | -38.89% |
| 2010 | 8.17 Million EUR | 299.68% |
| 2009 | -4.09 Million EUR | 27.69% |
| 2008 | -5.65 Million EUR | -75.53% |
| 2007 | -3.22 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 33.35 Million EUR | 0.0% |
| 2023 Q4 | 30.66 Million EUR | 0.0% |
| 2023 FY | 53.32 Million EUR | -18.02% |
| 2023 Q2 | 23.67 Million EUR | 0.0% |
| 2022 Q2 | 37.91 Million EUR | 0.0% |
| 2022 FY | 65.04 Million EUR | -33.25% |
| 2022 Q4 | 27.13 Million EUR | 0.0% |
| 2021 Q4 | 45.46 Million EUR | 0.0% |
| 2021 FY | 97.44 Million EUR | -7.73% |
| 2021 Q2 | 51.97 Million EUR | 0.0% |
| 2020 FY | 105.61 Million EUR | 475.66% |
| 2020 Q4 | 77.92 Million EUR | 0.0% |
| 2020 Q2 | 27.68 Million EUR | 0.0% |
| 2019 FY | 18.34 Million EUR | 4.3% |
| 2019 Q2 | 10.8 Million EUR | 0.0% |
| 2019 Q4 | 5.95 Million EUR | 0.0% |
| 2018 Q4 | 8.83 Million EUR | 0.0% |
| 2018 Q2 | 8.75 Million EUR | 0.0% |
| 2018 FY | 17.58 Million EUR | 35.74% |
| 2017 Q4 | 7.6 Million EUR | 0.0% |
| 2017 FY | 12.95 Million EUR | 169.34% |
| 2017 Q2 | 5.35 Million EUR | 0.0% |
| 2016 Q2 | 2.21 Million EUR | 0.0% |
| 2016 FY | 4.81 Million EUR | 2.56% |
| 2016 Q4 | 2.59 Million EUR | 0.0% |
| 2015 Q4 | 1.25 Million EUR | 0.0% |
| 2015 Q2 | 3.43 Million EUR | 0.0% |
| 2015 FY | 4.69 Million EUR | -41.24% |
| 2014 Q2 | 4.35 Million EUR | 0.0% |
| 2014 Q4 | 3.62 Million EUR | 0.0% |
| 2014 FY | 7.98 Million EUR | 4.31% |
| 2013 Q4 | 3.97 Million EUR | 0.0% |
| 2013 Q2 | 3.67 Million EUR | 0.0% |
| 2013 FY | 7.65 Million EUR | 54.98% |
| 2012 Q2 | - EUR | -100.0% |
| 2012 FY | 4.93 Million EUR | -1.1% |
| 2012 Q4 | - EUR | -100.0% |
| 2012 Q3 | 1.23 Million EUR | 0.0% |
| 2012 Q1 | 1.23 Million EUR | 0.0% |
| 2011 Q4 | - EUR | -100.0% |
| 2011 Q2 | - EUR | -100.0% |
| 2011 FY | 4.99 Million EUR | -38.89% |
| 2011 Q3 | 1.24 Million EUR | 0.0% |
| 2011 Q1 | 1.24 Million EUR | 0.0% |
| 2010 Q1 | 2.04 Million EUR | 0.0% |
| 2010 FY | 8.17 Million EUR | 299.68% |
| 2010 Q4 | - EUR | -100.0% |
| 2010 Q3 | 2.04 Million EUR | 0.0% |
| 2010 Q2 | - EUR | -100.0% |
| 2009 Q1 | -1.02 Million EUR | 27.69% |
| 2009 Q4 | - EUR | 100.0% |
| 2009 Q3 | -1.02 Million EUR | 0.0% |
| 2009 Q2 | -1.02 Million EUR | 0.0% |
| 2009 FY | -4.09 Million EUR | 27.69% |
| 2008 FY | -5.65 Million EUR | -75.53% |
| 2008 Q1 | -1.41 Million EUR | -75.53% |
| 2008 Q2 | -1.41 Million EUR | 0.0% |
| 2008 Q3 | -1.41 Million EUR | 0.0% |
| 2008 Q4 | -1.41 Million EUR | 0.0% |
| 2007 Q4 | -806 Thousand EUR | 0.0% |
| 2007 Q2 | -806 Thousand EUR | 0.0% |
| 2007 Q3 | -806 Thousand EUR | 0.0% |
| 2007 Q1 | -806 Thousand EUR | 0.0% |
| 2007 FY | -3.22 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Affluent Medical SA | -1.2 Million EUR | 4597.167% |
| Bluelinea Société Anonyme | -3.84 Million EUR | 1502.594% |
| Carmat SA | -30.97 Million EUR | 274.247% |
| Diagnostic Medical Systems S.A. | 15.84 Million EUR | -240.63% |
| Euromedis Groupe | 3.57 Million EUR | -1410.986% |
| Ikonisys S.A. | 255.82 Thousand EUR | -20994.724% |
| Implanet S.A. | 3.13 Million EUR | -1623.052% |
| Median Technologies SA | -2.55 Million EUR | 2215.484% |
| SpineGuard SA | 3.37 Million EUR | -1497.074% |
| Theraclion SA | -1.08 Million EUR | 5095.071% |
| Euroapi S.A. | 164.6 Million EUR | 67.214% |
| Guerbet SA | 197.14 Million EUR | 72.627% |
| Ion Beam Applications SA | 134.44 Million EUR | 59.859% |
| Koninklijke Philips N.V. | 7.44 Billion EUR | 99.275% |
| Sequana Medical NV | 548.04 Thousand EUR | -9746.93% |